Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b-2 study
乔垣结衣
7个月前
199
20
已关闭
DOI:
文献链接:
其他信息:

